Top 5 Stocks to Buy Now
→ Trump's New Dollar (From Porter & Company) (Ad)tc pixel Free FMS Stock Alerts

Fresenius Medical Care AG & Co. KGaA (FMS) Competitors

Fresenius Medical Care AG & Co. KGaA logo
$23.73 +0.34 (+1.45%)
Closing price 06/23/2026 03:58 PM Eastern
Extended Trading
$23.70 -0.03 (-0.11%)
As of 06/23/2026 07:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

FMS vs. NTRA, GH, BTSG, HIMS, and PACS

Should you buy Fresenius Medical Care AG & Co. KGaA stock or one of its competitors? MarketBeat compares Fresenius Medical Care AG & Co. KGaA with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Fresenius Medical Care AG & Co. KGaA include Natera (NTRA), Guardant Health (GH), BrightSpring Health Services (BTSG), Hims & Hers Health (HIMS), and PACS Group (PACS). These companies are all part of the "healthcare" industry.

How does Fresenius Medical Care AG & Co. KGaA compare to Natera?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and Natera (NASDAQ:NTRA) are both large-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, earnings, valuation, profitability, dividends, institutional ownership, analyst recommendations and media sentiment.

8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. Comparatively, 99.9% of Natera shares are owned by institutional investors. 5.1% of Natera shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Natera. Natera is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fresenius Medical Care AG & Co. KGaA$22.20B0.58$1.11B$1.9012.49
Natera$2.31B14.58-$208.16M-$1.63N/A

Fresenius Medical Care AG & Co. KGaA presently has a consensus target price of $28.00, suggesting a potential upside of 17.99%. Natera has a consensus target price of $257.71, suggesting a potential upside of 9.77%. Given Fresenius Medical Care AG & Co. KGaA's higher probable upside, equities research analysts plainly believe Fresenius Medical Care AG & Co. KGaA is more favorable than Natera.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fresenius Medical Care AG & Co. KGaA
5 Sell rating(s)
4 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.44
Natera
1 Sell rating(s)
4 Hold rating(s)
14 Buy rating(s)
2 Strong Buy rating(s)
2.81

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.88% compared to Natera's net margin of -9.05%. Fresenius Medical Care AG & Co. KGaA's return on equity of 8.90% beat Natera's return on equity.

Company Net Margins Return on Equity Return on Assets
Fresenius Medical Care AG & Co. KGaA4.88% 8.90% 4.05%
Natera -9.05%-14.74%-10.27%

In the previous week, Natera had 10 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 12 mentions for Natera and 2 mentions for Fresenius Medical Care AG & Co. KGaA. Natera's average media sentiment score of 0.99 beat Fresenius Medical Care AG & Co. KGaA's score of 0.85 indicating that Natera is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Fresenius Medical Care AG & Co. KGaA
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Natera
6 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Fresenius Medical Care AG & Co. KGaA has a beta of 0.8, suggesting that its stock price is 20% less volatile than the broader market. Comparatively, Natera has a beta of 1.56, suggesting that its stock price is 56% more volatile than the broader market.

Summary

Natera beats Fresenius Medical Care AG & Co. KGaA on 9 of the 17 factors compared between the two stocks.

How does Fresenius Medical Care AG & Co. KGaA compare to Guardant Health?

Guardant Health (NASDAQ:GH) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both large-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, media sentiment, valuation, institutional ownership, earnings, profitability, risk and analyst recommendations.

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.88% compared to Guardant Health's net margin of -40.10%. Fresenius Medical Care AG & Co. KGaA's return on equity of 8.90% beat Guardant Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Guardant Health-40.10% N/A -26.42%
Fresenius Medical Care AG & Co. KGaA 4.88%8.90%4.05%

In the previous week, Guardant Health had 7 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 9 mentions for Guardant Health and 2 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 0.85 beat Guardant Health's score of 0.10 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Guardant Health
3 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral
Fresenius Medical Care AG & Co. KGaA
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Guardant Health$982.02M17.67-$416.28M-$3.39N/A
Fresenius Medical Care AG & Co. KGaA$22.20B0.58$1.11B$1.9012.49

92.6% of Guardant Health shares are held by institutional investors. Comparatively, 8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. 5.6% of Guardant Health shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Guardant Health has a beta of 1.61, suggesting that its share price is 61% more volatile than the broader market. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.8, suggesting that its share price is 20% less volatile than the broader market.

Guardant Health currently has a consensus target price of $141.95, indicating a potential upside of 8.50%. Fresenius Medical Care AG & Co. KGaA has a consensus target price of $28.00, indicating a potential upside of 17.99%. Given Fresenius Medical Care AG & Co. KGaA's higher possible upside, analysts plainly believe Fresenius Medical Care AG & Co. KGaA is more favorable than Guardant Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Guardant Health
1 Sell rating(s)
0 Hold rating(s)
21 Buy rating(s)
1 Strong Buy rating(s)
2.96
Fresenius Medical Care AG & Co. KGaA
5 Sell rating(s)
4 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.44

Summary

Fresenius Medical Care AG & Co. KGaA beats Guardant Health on 9 of the 17 factors compared between the two stocks.

How does Fresenius Medical Care AG & Co. KGaA compare to BrightSpring Health Services?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and BrightSpring Health Services (NASDAQ:BTSG) are both large-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, valuation, institutional ownership, risk, media sentiment, earnings, dividends and profitability.

Fresenius Medical Care AG & Co. KGaA has a beta of 0.8, indicating that its share price is 20% less volatile than the broader market. Comparatively, BrightSpring Health Services has a beta of 1.87, indicating that its share price is 87% more volatile than the broader market.

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.88% compared to BrightSpring Health Services' net margin of 2.27%. BrightSpring Health Services' return on equity of 14.63% beat Fresenius Medical Care AG & Co. KGaA's return on equity.

Company Net Margins Return on Equity Return on Assets
Fresenius Medical Care AG & Co. KGaA4.88% 8.90% 4.05%
BrightSpring Health Services 2.27%14.63%4.41%

In the previous week, BrightSpring Health Services had 1 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 3 mentions for BrightSpring Health Services and 2 mentions for Fresenius Medical Care AG & Co. KGaA. BrightSpring Health Services' average media sentiment score of 0.88 beat Fresenius Medical Care AG & Co. KGaA's score of 0.85 indicating that BrightSpring Health Services is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Fresenius Medical Care AG & Co. KGaA
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
BrightSpring Health Services
3 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than BrightSpring Health Services. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fresenius Medical Care AG & Co. KGaA$22.20B0.58$1.11B$1.9012.49
BrightSpring Health Services$12.91B1.02$190.67M$1.4147.40

Fresenius Medical Care AG & Co. KGaA currently has a consensus price target of $28.00, indicating a potential upside of 17.99%. BrightSpring Health Services has a consensus price target of $61.27, indicating a potential downside of 8.34%. Given Fresenius Medical Care AG & Co. KGaA's higher probable upside, analysts plainly believe Fresenius Medical Care AG & Co. KGaA is more favorable than BrightSpring Health Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fresenius Medical Care AG & Co. KGaA
5 Sell rating(s)
4 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.44
BrightSpring Health Services
0 Sell rating(s)
0 Hold rating(s)
16 Buy rating(s)
2 Strong Buy rating(s)
3.11

8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. 2.8% of BrightSpring Health Services shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

BrightSpring Health Services beats Fresenius Medical Care AG & Co. KGaA on 11 of the 17 factors compared between the two stocks.

How does Fresenius Medical Care AG & Co. KGaA compare to Hims & Hers Health?

Hims & Hers Health (NYSE:HIMS) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, analyst recommendations, media sentiment, institutional ownership and earnings.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hims & Hers Health$2.37B3.22$128.37M-$0.09N/A
Fresenius Medical Care AG & Co. KGaA$22.20B0.58$1.11B$1.9012.49

63.5% of Hims & Hers Health shares are owned by institutional investors. Comparatively, 8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. 11.8% of Hims & Hers Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Hims & Hers Health has a beta of 2.37, indicating that its stock price is 137% more volatile than the broader market. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.8, indicating that its stock price is 20% less volatile than the broader market.

In the previous week, Hims & Hers Health had 22 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 24 mentions for Hims & Hers Health and 2 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 0.85 beat Hims & Hers Health's score of 0.81 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hims & Hers Health
11 Very Positive mention(s)
5 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Fresenius Medical Care AG & Co. KGaA
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Hims & Hers Health presently has a consensus target price of $29.37, suggesting a potential downside of 11.01%. Fresenius Medical Care AG & Co. KGaA has a consensus target price of $28.00, suggesting a potential upside of 17.99%. Given Fresenius Medical Care AG & Co. KGaA's higher probable upside, analysts plainly believe Fresenius Medical Care AG & Co. KGaA is more favorable than Hims & Hers Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hims & Hers Health
2 Sell rating(s)
10 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.13
Fresenius Medical Care AG & Co. KGaA
5 Sell rating(s)
4 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.44

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.88% compared to Hims & Hers Health's net margin of -0.56%. Fresenius Medical Care AG & Co. KGaA's return on equity of 8.90% beat Hims & Hers Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Hims & Hers Health-0.56% 6.10% 1.52%
Fresenius Medical Care AG & Co. KGaA 4.88%8.90%4.05%

Summary

Fresenius Medical Care AG & Co. KGaA beats Hims & Hers Health on 9 of the 16 factors compared between the two stocks.

How does Fresenius Medical Care AG & Co. KGaA compare to PACS Group?

PACS Group (NYSE:PACS) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, analyst recommendations, profitability, valuation, dividends, institutional ownership and media sentiment.

8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. 70.1% of PACS Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, PACS Group had 8 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 10 mentions for PACS Group and 2 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 0.85 beat PACS Group's score of -0.33 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
PACS Group
3 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Fresenius Medical Care AG & Co. KGaA
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

PACS Group currently has a consensus target price of $48.00, suggesting a potential upside of 28.72%. Fresenius Medical Care AG & Co. KGaA has a consensus target price of $28.00, suggesting a potential upside of 17.99%. Given PACS Group's stronger consensus rating and higher possible upside, equities analysts plainly believe PACS Group is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PACS Group
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71
Fresenius Medical Care AG & Co. KGaA
5 Sell rating(s)
4 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.44

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.88% compared to PACS Group's net margin of 4.49%. PACS Group's return on equity of 26.47% beat Fresenius Medical Care AG & Co. KGaA's return on equity.

Company Net Margins Return on Equity Return on Assets
PACS Group4.49% 26.47% 4.36%
Fresenius Medical Care AG & Co. KGaA 4.88%8.90%4.05%

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than PACS Group. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PACS Group$5.29B1.12$191.54M$1.5623.90
Fresenius Medical Care AG & Co. KGaA$22.20B0.58$1.11B$1.9012.49

Summary

PACS Group beats Fresenius Medical Care AG & Co. KGaA on 9 of the 15 factors compared between the two stocks.

Get Fresenius Medical Care AG & Co. KGaA News Delivered to You Automatically

Sign up to receive the latest news and ratings for FMS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FMS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FMS vs. The Competition

Export
MetricFresenius Medical Care AG & Co. KGaAMED INSTRUMENTS IndustryMedical SectorNYSE Exchange
Market Cap$12.63B$7.05B$6.44B$23.25B
Dividend Yield2.59%1.28%2.69%4.07%
P/E Ratio12.4948.6524.6631.08
Price / Sales0.5876.50528.6416.29
Price / Cash4.2024.7844.8224.45
Price / Book0.827.1310.794.64
Net Income$1.11B$159.20M$3.56B$1.07B
7 Day Performance0.68%-0.98%1.01%0.15%
1 Month Performance9.38%-1.97%0.43%0.18%
1 Year Performance-14.69%5.08%29.71%23.21%

Fresenius Medical Care AG & Co. KGaA Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FMS
Fresenius Medical Care AG & Co. KGaA
4.2595 of 5 stars		$23.73
+1.5%		$28.00
+18.0%		-12.6%$12.63B$22.20B12.491,488
NTRA
Natera
3.4117 of 5 stars		$216.97
+2.3%		$256.53
+18.2%		+37.8%$30.37B$2.31BN/A6,140
GH
Guardant Health
2.191 of 5 stars		$129.82
-1.4%		$141.95
+9.3%		+169.5%$17.45B$982.02MN/A2,506
BTSG
BrightSpring Health Services
4.0757 of 5 stars		$64.08
+1.3%		$58.53
-8.7%		+193.5%$12.47B$12.91B45.4523,500
HIMS
Hims & Hers Health
3.0864 of 5 stars		$30.10
+12.2%		$28.70
-4.6%		-21.6%$6.21B$2.35BN/A2,442

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NYSE:FMS) was last updated on 6/24/2026 by MarketBeat.com Staff.
From Our Partners
My feud with Zohran Mamdani
Nearly 40% of Americans now hold a positive view of socialism - and former hedge fund manager Whitney Tilson s...
Stansberry Research | Sponsoredtc pixel
Quick favor to ask you
Bill Poulos is giving away his 'Safe Trade Options Formula' book at no charge - the same book that sells for $...
Profits Run | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Top Banks Warn: A Strange Day is Coming to America
Goldman Sachs and Morgan Stanley are warning clients about a developing crisis that could suppress portfolio g...
TradeSmith | Sponsoredtc pixel
A drilling crew just broke a record nobody expected
A drilling crew in Beaver County, Utah hit 15,765 feet of solid granite in 16 days - a job the Department of E...
Behind the Markets | Sponsoredtc pixel
Millionaire trader who went 13-for-13 on Trump in 2025 now turns his attention to Elon.
Hedge fund trader Larry Benedict went 13-for-13 in Q1 2025 - not a single losing trade - and finished the year...
Brownstone Research | Sponsoredtc pixel
Karp just filed Form 144
On May 12, 2026, Palantir CEO Alex Karp filed to sell 585,000 shares - roughly $95.93 million. Combined with f...
Porter & Company | Sponsoredtc pixel
PH: Do THESE 4 things to your bank account now …
In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...
Weiss Ratings | Sponsoredtc pixel